(VUSB) Vanguard Ultra-Short Bond - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US92203C3034

Fixed Income Securities, Ultrashort-Term Bonds, Exchange-Traded Fund

Description: VUSB Vanguard Ultra-Short Bond

The First Trust Ultra-Short Bond ETF ETF (FUSB) is designed to provide liquidity and preserve capital by investing in a diversified portfolio of high-quality fixed income securities, with a smaller allocation to lower-quality issues. The funds investment strategy iss focused on maintaining a dollar-weighted average maturity of 0 to 2 years, allowing it to be highly responsive to changes in interest rates.

Under normal circumstances, at least 80% of the funds assets are invested in fixed income securities. This approach is geared towards minimizing risk while generating returns that are slightly higher than those available from traditional savings accounts or money market funds. The funds overview indicates it is categorized as an Ultra-Short Bond ETF, originating from the USA States, traded under the ticker symbol FUSB on the BATS exchange.

Combining historical technical data with fundamental insights, we can infer that the fund has demonstrated stability, as indicated by its technical_data. A forecast based on these data points suggests that the fund will likely continue to maintain its current price range, potentially edging higher due to its inherent characteristics and the prevailing market conditions. With an Assets Under Management (AUM) of of around 5.3 billion USD, as per the funds fundamental data, it is well-positioned to capitalize on opportunities in the fixed income income market.

Given the funds investment strategy and market conditions, a plausible forecast is that the First Trust Ultra-Short Bond ETF will continue to attract investors seeking low-risk investment options with competitive yields. As interest rates evolve, the fund is poised to adjust its portfolio accordingly, maintaining its average maturity within the targeted range. This adaptability, combined with its diversified holdings, is expected to support the funds stability and performance.

Additional Sources for VUSB ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

VUSB ETF Overview

Market Cap in USD 5,332m
Category Ultrashort Bond
TER 0.10%
IPO / Inception 2021-04-06

VUSB ETF Ratings

Growth Rating 66.7
Fundamental -
Dividend Rating 73.2
Rel. Strength 7.61
Analysts -
Fair Price Momentum 51.74 USD
Fair Price DCF -

VUSB Dividends

Dividend Yield 12m 4.60%
Yield on Cost 5y 5.17%
Annual Growth 5y 110.27%
Payout Consistency 80.0%
Payout Ratio %

VUSB Growth Ratios

Growth Correlation 3m 99%
Growth Correlation 12m 99.8%
Growth Correlation 5y 85.3%
CAGR 5y 3.12%
CAGR/Max DD 5y 1.74
Sharpe Ratio 12m 1.10
Alpha 1.40
Beta 0.003
Volatility 0.77%
Current Volume 798.5k
Average Volume 20d 907.7k
Stop Loss 48 (-3.4%)
What is the price of VUSB shares?
As of July 10, 2025, the stock is trading at USD 49.71 with a total of 798,545 shares traded.
Over the past week, the price has changed by +0.05%, over one month by +0.51%, over three months by +1.45% and over the past year by +5.63%.
Is Vanguard Ultra-Short Bond a good stock to buy?
Yes. Based on ValueRay's Analyses, Vanguard Ultra-Short Bond (BATS:VUSB) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 66.65 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VUSB is around 51.74 USD . This means that VUSB is currently overvalued and has a potential downside of 4.08%.
Is VUSB a buy, sell or hold?
Vanguard Ultra-Short Bond has no consensus analysts rating.
What are the forecasts for VUSB share price target?
According to our own proprietary Forecast Model, VUSB Vanguard Ultra-Short Bond will be worth about 55.9 in July 2026. The stock is currently trading at 49.71. This means that the stock has a potential upside of +12.41%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 55.9 12.4%